Navigation Links
Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of the American Society of Clinical Oncology has published the early results of a clinical study conducted by Dr. Siu-Fun Wong, and her colleagues, which concluded that the topical gel, Regenecare(R), caused a statistically significant reduction in the pain and itching of a rash that results from the use of anti-cancer drugs known as EGFR inhibitors. This ongoing supportive care trial is listed on the National Cancer Institute Clinical Trials website (www.cancer.gov).

Paul Miller, President of MPM Medical, stated, "EGFR inhibitors form a group of drugs, sold by several pharmaceutical companies, which are effective in the treatment of cancer. However, after a few weeks of use, an acne-like rash often appears on the face, neck, back, hands, and/or legs resulting in severe pain and itching for the patient. We know of no other evidence-based topical applications reported in the scientific literature shown to help manage rash symptoms caused by EGFR drugs."

Regenecare(R) is a proprietary product of MPM Medical, Inc., a wholly owned subsidiary of RBC Life Sciences, Inc. (OTCBB:RBCL).

MPM Medical develops and markets a line of prescription and nonprescription products for wound management, through medical-surgical dealers, to nursing homes, hospitals, and cancer clinics.

The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

Contact

RBC Life Sciences, Inc.
Steve Brown, CFO, 972-893 4000





Page: 1 2

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... THOUSAND OAKS, Calif. , May 16, 2013  Amgen ... Global Life Sciences Conference on Tuesday, May 21, 2013, at ... York City , beginning at 10:00 a.m. Eastern Daylight ... senior vice president of Research and Development at Amgen, will ... be accessed from the Events Calendar on Amgen,s website, ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Corporation (Nasdaq: KNSY ) announced today that it ... facility with Wells Fargo Bank, National Association. The ... on May 25, 2014, with the option to extend it ... conditions. The credit facility allows the Company to use borrowings ...
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... filed by its wholly owned subsidiary, Savient Pharma ... the treatment of chronic gout in adult patients ... the European Medicines Agency (EMA).  The MAA has ...
Cached Medicine Technology:Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 2Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 3Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 4
(Date:5/20/2013)... AURORA, Colo. – May 20, 2013 ... has developed a Bachelor of Science Nursing (BSN) ... feel about continuing their education and gauge their readiness ... complimentary worksheet, respond to ten statements and then tally ... a BSN-readiness scale. , New industry standards and complexities ...
(Date:5/20/2013)... 2013 Can you tell a joke well? , ... joke? , Would you like to be funnier as a speaker, ... your funny bone is missing? , Can't think of a snappy ... , If this sounds like you, don't worry. Help is ... sense of humor; and even learn to tell a joke well. ...
(Date:5/20/2013)... 2013 The transvaginal mesh lawyers at ... firm, report that two important bellwether trials are set ... and federal litigations established for C.R. Bard transvaginal ... C.R. Bard bellwether trial will begin in the federal ... Virginia. (In re: C.R. Bard, Inc., Pelvic Repair ...
(Date:5/20/2013)... Olympia, WA (PRWEB) May 20, 2013 ... privacy solutions, today announced that the company’s Alliance ... TrueCrypt password management with Key Connection for ... and use cryptographically strong passwords when using TrueCrypt ... first company to offer secure password management for ...
(Date:5/20/2013)... 20, 2013 Gerald Wojtala, executive director ... speak at North Carolina Food Safety and Defense Task ... The Need for Partnerships – from Farm to Fork ... scheduled for May 22-23 at the Sheraton Imperial Hotel, ... food sector have in protecting the food supply. , ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3Health News:IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference 2
... the lives of wild and laboratory rodents seems to throw ... exposed //to germs in the environment, rather than protecting against ... University analyzed the immune systems of mice and rats which ... ,Senior researcher William Parker said, "Laboratory rodents ...
... of subjecting drug addicts to shock therapy as a means ... controversies. Now, the Scottish Executive is doing more research into ... labeled as Neuro-Electric Therapy (NET) is executed with the use ... pulses are sent into the brain. This is known to ...
... A two year old, Stephen Carr’s life hangs between life ... acidosis, that requires //a double kidney transplant, which will give ... have the perfect match, so they will be donating a ... other children, said: "As parents we felt so helpless, especially ...
... Francisco Zoo had knowingly imported parakeets with a contagious and ... //. ,While the disease is not infectious cannot ... causes psittacine beak and feather disease could pose a threat ... system causing abnormal feather growth and beak deformities. No known ...
... flu virus found in poultry in Hungary last week was ... //. ,As chief veterinarian Miklos Suth said,‘This afternoon ... the highly pathogenic H5N1 strain of avian influenza which had ... report of the H5N1 virus in poultry in Hungary. ...
... Deadly H5N1 virus is been brought into New Zealand by ... ,At Wallaceville, country's highest security laboratory holds the threatening substance ... ,Joseph O'Keefe, the Wallaceville manager said it ... was kept inside a freezer. Well-trained staffs, wearing safe suits ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: